Biodesix, Inc.
BDSXDiagnostics & Research
$23.26−5.93%As of Oct 30vs prior close
- Market cap
- $245.4M
- P/E (TTM)
- –
- Implied growth
- –
- From 52W high
- −24.00%
- EPS (LTM)
- -$3.11
- Revenue (LTM)
- $102.9M
- Net margin
- -26.97%
- Dividend yield
- 0.00%
Nomior Score
48
Ascendant MoverSpeculativeBottom 45% of the scored universe
Growth71
Quality22
Value37
Momentum99
Resilience19
Growth
+23.83%revenue a year over 6 fiscal years
YE19 $24.6MLTM $102.9M
Connections
Revenue to profitQ2 YE26
The operating loss was 20% of revenue, narrower by 28 pts on a year.
Who owns it
1fund